Healthcare Industry News: CONMED
News Release - July 9, 2021
Single Pass Closes Seed Funding RoundLAKE FOREST, Calif., July 9, 2021 -- (Healthcare Sales & Marketing Network) -- Bill Colone, CEO, announced today the closing of the seed financing round for Single Pass, Inc. (www.singlepass.co). Single Pass has developed the world's first disposable bipolar electrocautery device that can cauterize deep tissue through a guide needle. The investment round was led by Tech Coast Angels, San Diego and also included Kyto Technology and Life Science, Inc. located in Los Altos Hills, California.
Over four million deep tissue biopsy procedures are performed annually throughout the world and the market continues rapid growth due to new tissue imaging and detection methods. Uncontrolled bleeding and hemorrhage are potential complications for which there are no current electro-cautery solutions. The company is targeting 2022 for the commercial introduction of the new device both in the US and internationally.
Current biopsy procedure equipment manufacturers include Becton Dickinson and Company, Cook Group Incorporated, Merit Medical Systems, Olympus Corporation, Medtronic, CONMED Corporation, and Boston Scientific Corporation.
Source: Single Pass Inc
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.